|
December 21, 2017 0:30 - FDA approves adjuvant BMS’ nivolumab for melanoma https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-receives-fda-approval-opdivo-nivolumab-ad 3:15 - FDA approves Genentech’s adjuvant pertuzumab regimen for HER2+ breast cancer https://www.gene.com/media/press-releases/14703/2017-12-20/fda-approves-genentechs-perjeta-pertuzum 6:26 - FDA approves Pfizer and Merck's ertugliflozin for Type 2 diabetes http://www.mdmag.com/medical-news/fda-approves-pfizer-and-mercks-ertugliflozin-for-type-2-diabetes Brought to you by == NASCENT MEDICAL Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. They do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials contact info@nascentmc.com == First episode of AI in Medicine Podcast is coming out on Wednesday January 4th, 2018. I will be talking with Dr. Alex Zhavoronkov who is the is the CEO of InSilico Medicine, Inc https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000?mt=2 The episode after that, I’ll be talking with Dawn Laney and Dave Jacob founders of ThinkGenetic.com a company uses artificial intelligence (AI) solutions to improve the speed to diagnosis. and then after that, Mark Michalky MD, Executive Director of MGH and BWH Center for Clinical Data Science Will be covering Precision Medicine World conference taking place in Jan 2018 in Silicon Valley :) pmwcintl.com |